PubMed HealthSearch

PubMed · 6591990

Viscometric methods for assessing red cell deformability and fragmentation.

Abstract

Erythrocyte deformability is an important determinant of red cell life span and depends on at least three key factors: shape, internal viscosity and membrane mechanical properties. In this paper we describe three viscometric methods for assessing red cell deformability and fragmentation: 1) Plasma and whole blood are sheared with a coneplate viscometer at high shear rates. A mathematical model for liquid behaviour is applied to the results from plasma and whole blood viscosity, and a rheological parameter called internal viscosity is obtained. 2) Shearing packed red cells (Haematocrit greater than or equal to 95%) at high shear rates, a mechanical fragmentation curve is obtained, and a new rheological parameter called rupture stress is determined. 3) Shearing whole blood at 230 Sec-1 and increasing continuously the temperature from 37 degrees C to 57 degrees C, a thermic curve is obtained. A viscosity increase is observed at about 48 degrees C and thermic curve changes are related to effects of heat on the red cell membrane. Internal viscosity, mechanical fragmentation curve and thermic curve assess red cell deformability and fragmentation and can be used as diagnostic tools in diseases with red cell abnormalities.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L Berga, J Dolz, J L Vives-Corrons, E Feliu, C Rozman. 1984. Viscometric methods for assessing red cell deformability and fragmentation.. https://doi.org/10.3233/bir-1984-23s153

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Erythropoietin in diabetic macular edema and renal insufficiency.

Erythropoietin was administered to five anemic azotemic diabetic subjects for 1 year to assess the effect of increasing red cell mass on clinical well-being and the course of renal functional decline. None of the subjects manifested worsened hypertension or cerebrovascular or cardiovascular complications despite an increase in mean hematocrit from a baseline mean of 29.6% to a mean of 39.5%. The serum creatinine concentration after 1 year of treatment with erythropoietin was 3.7 mg/dL, which was unchanged from the baseline value of 3.5 mg/dL. Plasma viscosity remained constant as red cell mass increased. Although the viscosity of whole blood rose as the hematocrit increased, it was within the range of normal blood viscosity for an equivalent hematocrit. The favorable impact of erythropoietin treatment on three diabetic subjects who had macular edema and anemia is described. One hypothesis to explain the benefit of a raised hematocrit on both diabetic nephropathy and retinopathy is that the metabolic, hormonal, and hemodynamic components of the diabetic syndrome, in concert, produce tissue and cellular hypoxia that is ameliorated in part by the greater oxygen-transporting capacity of a raised red cell mass. The pseudohypoxia of diabetes may be implicated in the pathogenesis of diabetic neuropathy, retinopathy, muscular dysfunction, and nephropathy.

Blood Viscosity